Overview Fundamentals API Earnings EOD API Sample Code Pricing

Syros Pharmaceuticals Inc (SYRS NASDAQ) stock market data APIs

$1.53 0.03(2%) as of September 9, 2024
Price chart is built with Anychart

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.

Syros Pharmaceuticals Inc Financial Data Overview

1.5
1.53
-
1.567
1.48
1.48-8.17
40 215 K
26 810 K
4 149 K
-0.59
1.579
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SYRS',
Type: 'Common Stock',
Name: 'Syros Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG004FFTL76',
ISIN: NULL,
CUSIP: NULL,
CIK: '1556263',
EmployerIdNumber: '45-3772460',
FiscalYearEnd: 'December',
IPODate: '2016-06-30',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Syros Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 149 K
  • EBITDA -115 995 000
  • Earnings Per Share -4.35
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Syros Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-07-31
  • EPS/Forecast -0.77

Get Syros Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com